COBENFY for the Treatment of Schizophrenia, US
COBENFY™ (xanomeline and trospium chloride) is an antipsychotic drug combining xanomeline, a muscarinic acetylcholine receptor (mAChR) agonist, and trospium chloride, …
Projects
-
-
BALVERSA for the Treatment of Urothelial Carcinoma, US
BALVERSA® (erdafitinib) is a fibroblast growth factor receptor (FGFR) kinase inhibitor indicated for the treatment of patients with locally advanced or …
-
Iqirvo for the Treatment of Primary Biliary Cholangitis, US
Iqirvo® (elafibranor) is a first-in-class peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of primary biliary cholangitis (PBC) in …
-
Sarclisa (isatuximab) for the Treatment of Multiple Myeloma, USA
Sarclisa® (isatuximab) is a monoclonal antibody indicated, in combination with pomalidomide and dexamethasone (pom-dex), for the treatment of multiple myeloma …
-
FRUZAQLA (fruquintinib) for the Treatment of Metastatic Colorectal Cancer, USA
FRUZAQLA® (fruquintinib) is a kinase inhibitor indicated to treat adults with metastatic colorectal cancer (mCRC). It is a novel oral targeted …
-
VYLOY (zolbetuximab) for the Treatment of Gastric Cancer, Japan
VYLOY™ (zolbetuximab) is an anti-claudin (CLDN)-18.2 monoclonal antibody used in conjunction with chemotherapy for the treatment of patients with human …
-
NIKTIMVO for the Treatment of cGvHD, US
NIKTIMVO™ (axatilimab) is a first-in-class anti-colony stimulating factor-1 receptor (CSF-1R) antibody indicated for treating the chronic graft-versus-host disease (cGvHD) in …
-
Wegovy for the Treatment of Chronic Weight Management, US
Wegovy® (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced diet and increased exercise …
-
Livdelzi (Seladelpar) for the Treatment of Primary Biliary Cholangitis, USA
Livdelzi® (seladelpar) is a novel, selective peroxisome proliferator-activated receptor delta (PPARδ) agonist. It is indicated for the treatment of primary …
-
TECELRA (afamitresgene autoleucel) for the Treatment of Synovial Sarcoma, USA
TECELRA® (afamitresgene autoleucel) is an autologous T-cell immunotherapy indicated for adults with unresectable or metastatic synovial sarcoma who test positive …
-
VORANIGO (vorasidenib) for the Treatment of Grade 2 IDH-mutant Glioma, USA
VORANIGO® (vorasidenib) is an isocitrate dehydrogenase (IDH) inhibitor indicated for the treatment of adults and children aged 12 years and …
-
ELAHERE for the Treatment of Ovarian Cancer, US
ELAHERE® (mirvetuximab soravtansine) is a novel antibody-drug conjugate (ADC) indicated for the treatment of adult patients with folate receptor alpha …
-
Haiyitan for the Treatment of Non-Small Cell Lung Cancer, Japan
Haiyitan® (gumarontinib hydrate) is an oral mesenchymal-epithelial transition factor (MET) inhibitor, discovered and developed by Haihe Biopharma, a biotechnology company …
-
ELREXFIO (elranatamab) for the Treatment of Multiple Myeloma, USA
ELREXFIO™ (elranatamab) is an off-the-shelf (ready-to-use) fixed-dose bispecific monoclonal antibody indicated for the treatment of adult patients with relapsed or …
-
QALSODY (tofersen) for the Treatment of Amyotrophic Lateral Sclerosis, Europe
QALSODY® (tofersen) is a targeted therapy designed for the treatment of amyotrophic lateral sclerosis (ALS) in adults carrying a superoxide …
